Women's Health
|
October 16, 2024

Effective Hair Replacement for Women: Top Treatments and Solutions

Written By
Medically Reviewed by
Updated On
October 29, 2024

Hair loss in women is a common yet often overlooked issue that can significantly impact self-esteem and quality of life. While male pattern baldness is widely discussed, female hair loss affects up to 50% of women at some point in their lives.

Female hair loss can stem from various factors, including genetics, hormonal changes, medical conditions, and aging. Unlike men, women typically experience diffuse thinning across the scalp rather than complete baldness in specific areas. 

An individual’s psychological and social well-being can be profoundly impacted by hair loss, often leading to decreased self-esteem, anxiety, and social withdrawal. This article delves into the various hair replacement treatments and solutions for women.

[signup]

Understanding Female Hair Loss

Female hair loss primarily manifests in two main types: female pattern hair loss (FPHL) and telogen effluvium (TE).

Female Pattern Hair Loss (FPHL)

FPHL, also known as female androgenetic alopecia, is the most common form of hair loss in women. It is characterized by:

  • Progressive miniaturization (decreased size) of hair follicles
  • Gradual thinning of hair, particularly in the central, frontal, and parietal scalp regions
  • Preservation of the frontal hairline in most cases

Unlike male pattern baldness, FPHL rarely leads to complete baldness. The prevalence of FPHL increases with age, affecting a significant portion of the female population.

Telogen Effluvium (TE)

TE is a temporary form of hair loss characterized by:

  • Sudden, diffuse shedding of hair
  • Often triggered by stress, hormonal changes, or nutritional deficiencies
  • Usually reversible once the underlying cause is addressed

Etiology and Risk Factors

The etiology of female hair loss is complex and consists of a variety of factors:

  • Genetic Predisposition: While specific genes for FPHL are still being investigated, there is a clear hereditary component.
  • Hormonal Factors: Androgens play a role, but many women with FPHL have normal androgen levels, suggesting other mechanisms are involved.
  • Age: The risk of FPHL increases with age.
  • Medical conditions: Thyroid disorders, iron deficiency, and other systemic diseases can contribute to hair loss.
  • Environmental factors: Stress, diet, and certain medications can influence hair loss

Surgical Hair Replacement Options

While female pattern hair loss is a progressive condition characterized by gradual thinning and miniaturization of hair follicles, surgical options like hair transplantation offer the closest approach to a permanent solution. 

Follicular Unit Transplantation (FUT)

Follicular Unit Transplantation (FUT) remains an effective surgical technique for hair replacement in women with female pattern hair loss. FUT offers several advantages: 

  • No need to shave recipient sites
  • Shorter operative times compared to follicular unit excision (FUE) techniques
  • A high success rate in treating various stages of hair loss

A comprehensive study of 751 female patients undergoing FUT over 31 years provided valuable insights into the procedure's efficacy. The average patient age was 48 years, with hair loss severity distributed as follows: 

  • 40% Ludwig stage I (small areas)
  • 45% Ludwig stage II (medium areas)
  • 15% Ludwig stage III (large areas)

Eighteen percent of patients underwent a second procedure after an average of 4 years, indicating the progressive nature of female pattern hair loss. Complications were rare, with donor-site scar widening occurring in 0.8% of cases and folliculitis in 2.3% of patients.

Follicular Unit Excision (FUE)

Follicular Unit Excision (FUE) is an alternative surgical method for women with androgenetic alopecia. This minimally invasive technique utilizes a punch device to harvest individual follicular units, avoiding the linear scarring associated with traditional strip surgery. FUE can be performed with partial shaving of the donor area, making it more appealing to some female patients. 

Non-Surgical Hair Replacement for Women

There are many effective options for women for non-surgical hair replacement. These treatments allow them to regain volume and confidence without invasive procedures.

Medication

Pharmacological interventions for female hair loss focus on three key treatments: minoxidil, finasteride, and dutasteride.

Minoxidil for Women

Minoxidil is a widely used topical treatment for female-pattern hair loss, available in 2% and 5% formulations. Its topical application stimulates hair growth, with studies showing that the 5% formulation demonstrates greater efficacy than the 2% version in treating female-pattern hair loss.

A study of 54 women using 2% minoxidil solution in combination with a botanical hair solution showed significant improvement in hair growth as early as 6 weeks, with increased patient satisfaction and self-confidence.

Finasteride

Finasteride, an oral medication primarily used for male pattern baldness, has shown limited evidence for efficacy in women. Due to potential teratogenic effects, its use is mainly restricted to postmenopausal women. While it has been a staple in male hair loss treatment, its application in female patients remains limited and requires careful consideration.

Dutasteride 

Dutasteride, a more potent 5α-reductase inhibitor than finasteride, has shown promise in treating male androgenetic alopecia. However, its use in women is not well-established. Further research is needed to determine its efficacy and safety profile for female pattern hair loss.

Scalp Treatments

Scalp treatments offer promising alternatives for individuals who want to address hair loss without surgery. These treatments can be used independently or with other therapies to enhance results.

Platelet-Rich Plasma Therapy

Platelet-rich plasma (PRP) Therapy uses the patient's own blood plasma to promote hair growth. The procedure involves drawing blood, processing it to concentrate platelets, and injecting the resulting plasma into the scalp. A typical treatment regimen consists of three sessions spaced 4-6 weeks apart, with maintenance treatments every 4-6 months.

Low-Level Laser Therapy

Low-Level Laser Therapy (LLLT) employs red light to stimulate hair follicles. Devices range from in-office hoods to at-home helmets and combs. Treatment protocols vary but often involve 2-3 weekly sessions, each lasting 20-30 minutes. 

A randomized, double-blind study of 146 male and female patients showed a 39% increase in hair growth in the LLLT group compared to 27% in the sham device group after 16 weeks. LLLT is considered safe, and no significant side effects have been reported.

Hair Systems and Wigs

Hair systems and wigs provide a non-surgical option for immediate cosmetic improvement for women experiencing hair loss. 

These solutions come in various types, including synthetic and human hair options. Hair systems can be particularly suitable for extensive hair loss, offering a practical, effective, and immediate way to enhance appearance. Additionally, they serve as a temporary solution for those undergoing medical treatments that may cause hair loss, such as chemotherapy.

The versatility of hair systems and wigs makes them a popular choice among women dealing with hair loss due to conditions like alopecia or the effects of chemotherapy. Many women find that wearing wigs helps them regain confidence and feel more comfortable in social situations. 

Emerging Therapies

Recent advancements in hair biology research have led to the development of novel targeted therapies for female hair loss. 

Proteoglycan Replacement Therapy

Proteoglycan replacement therapy, such as Nourkrin® with Marilex®, is promising for treating diffuse hair loss in women. This approach aims to restore the normal hair growth cycle by replenishing essential proteoglycans in the hair follicle.

Nourkrin® Woman is administered orally as tablets, with a typical dosage of 600mg of Marilex® per day, usually split into two tablets. The treatment is generally recommended for at least 6 months, with initial improvements often visible after 3 months. Clinical studies have shown promising results, with 94.03% of participants reporting improved hair growth and 95.52% noting enhanced hair appearance after just three months of treatment.

Stem Cell Treatments

Stem cell therapy for hair loss is a developing area of research that shows potential for treating various forms of alopecia. This approach utilizes the regenerative properties of stem cells to promote hair growth and possibly create new hair follicles.

Adipose-derived stem cells (ADSCs) are harvested from the patient's fat tissue and injected into the scalp. These cells stimulate existing hair follicles and improve the surrounding environment, potentially increasing hair density.

RNA Interference (RNAi) Technology

Small Interfering RNA (siRNA) is being researched as a potential treatment for androgenetic alopecia (AGA). This therapy specifically targets genes involved in hair loss, which may provide a more focused approach than existing medications.

By silencing the androgen receptor (AR) gene, siRNA aims to address the underlying genetic factors contributing to AGA directly. Early studies suggest that this targeted method could lead to more effective treatment outcomes, although further research is needed to validate its long-term efficacy and safety.

Growth Factors

Various growth factors are being studied for their potential in hair restoration. While these growth factors show promise in preclinical and early clinical studies, more research is needed to establish their long-term efficacy and safety in treating female hair loss.

VEGF 

VEGF promotes angiogenesis and is essential for hair growth and cycling. Studies have shown that VEGF can stimulate hair growth, increase hair follicle size, and enhance hair thickness. IGF-1 is involved in regulating cellular proliferation and differentiation in hair follicles. It has been found to prolong the anagen phase of the hair cycle and prevent hair follicle regression.

FGF

FGF, particularly FGF-7 (also known as keratinocyte growth factor), has been shown to promote hair growth by stimulating hair follicle development and keratinocyte proliferation. In one study, the application of FGF-7 to mouse skin resulted in a significant increase in the number of hair follicles.

Choosing the Best Hair Replacement Method for Women

The selection of the most appropriate hair replacement method for women depends on several factors:

Factors to Consider

  1. Extent and pattern of hair loss: The severity and distribution of hair thinning or loss will influence the most suitable treatment approach.
  2. Donor hair availability: The quantity and quality of available donor hair is crucial for successful surgical procedures.
  3. Patient's age and overall health: Age can affect hair loss progression and treatment outcomes, while overall health may impact suitability for certain procedures.
  4. Budget constraints: The cost of different treatments varies significantly, and long-term expenses should be considered alongside initial costs.
  5. Desired outcome and timeline: Patients should have realistic expectations about results and the time required to achieve them.
  6. Willingness to undergo surgery: Some individuals may prefer non-invasive options, while others are open to surgical interventions.
  7. Potential for future hair loss: Consider the likelihood of continued hair loss and how this may affect long-term results.
  8. Lifestyle factors: Occupation, physical activities, and personal grooming habits may influence treatment choice and maintenance.

Treatment Options Comparison

Numerous treatment options are available for female hair restoration, each with its own set of advantages and considerations. To help clarify the options available to patients, let's compare some of the main treatment approaches:

Cost Considerations

Hair transplantation offers two primary surgical techniques: Follicular Unit Transplantation (FUT) and Follicular Unit Excision (FUE). Cost variance can depend on various factors, including the patient's hair loss pattern, donor hair availability, and personal preferences.

Surgical Options

The choice between FUT and FUE depends on various factors, including the patient's hair loss pattern, donor hair availability, and personal preferences.

Follicular Unit Transplantation (FUT) Cost Range

FUT, also known as the strip method, typically costs between $4,000 and $15,000 per session. The price varies based on the number of grafts required and the surgeon's expertise. This technique involves removing a strip of scalp from the donor area, which is then dissected into individual follicular units for transplantation.

Follicular Unit Excision (FUE) Cost Range

FUE, on the other hand, generally ranges from $5,000 to $20,000 per session. It tends to be more expensive than FUT due to the increased labor in extracting follicular units from the donor area. This method leaves no linear scar and allows for a quicker recovery time, which may justify the higher cost for some patients.

Non-Surgical Options

Nonsurgical therapies are gaining attention for their potential effectiveness and lower invasiveness compared to surgical methods, although ongoing research is necessary to confirm their long-term efficacy and safety.

Minoxidil Costs

Minoxidil is a widely available over-the-counter treatment for hair loss, with a monthly cost ranging from $10 to $50, resulting in an annual expense of $120 to $600. This topical medication is FDA-approved for both men and women and has shown efficacy in promoting hair growth.

Low-Level Laser Therapy (LLLT) Costs

Low-Level Laser Therapy (LLLT) devices represent a one-time investment of $200 to $1,000. These at-home devices use red light to stimulate hair follicles and have demonstrated effectiveness in both male and female pattern hair loss.

Platelet-Rich Plasma Therapy Costs

Platelet-rich plasma (PRP) Therapy costs between $500 and $2,000 per session and typically requires multiple treatments for optimal results. This procedure uses the patient's own blood plasma to stimulate hair growth and has shown promise in recent studies.

Hair System’s Costs

Hair systems offer both custom and ready-made options. Custom systems range from $1,000 to $3,000, while ready-made alternatives cost between $200 and $1,000. Ongoing maintenance expenses for hair systems are estimated at $150 to $500 annually. 

Insurance Coverage

Most hair replacement treatments are considered cosmetic and not covered by insurance. Exceptions may exist for hair loss due to medical conditions or treatments.

Cost-Effectiveness Considerations

When evaluating hair restoration options, balancing upfront expenses and long-term maintenance costs can help patients make informed decisions that align with their financial situation and desired results.

  • Surgical options have higher upfront costs but may be more cost-effective long-term.
  • Non-surgical options often require ongoing expenses for maintenance
  • Combination treatments may provide optimal results but increase overall costs

[signup]

Key Takeaways

When advising patients on hair replacement options for women:

  • Each patient's hair loss pattern, medical history, and personal preferences should guide treatment recommendations.
  • FUT and FUE can provide long-lasting results for suitable candidates, with FUT showing high success rates across various stages of female pattern hair loss.
  • Minoxidil and low-level laser therapy (LLLT) are effective first-line treatments, especially for early-stage or diffuse thinning.
  • Proteoglycan replacement therapy shows promise for diffuse hair loss, but more research is needed on long-term efficacy.
  • Integrating surgical and non-surgical methods may offer optimal outcomes for many patients.
  • Discuss the range of treatment costs and long-term maintenance requirements to help patients make informed decisions. Emphasize the importance of regular follow-ups to monitor treatment efficacy and adjust plans as needed.
  • Educate patients on the progressive nature of female pattern hair loss and the potential need for ongoing treatments.
  • Recognize hair loss's emotional and psychological aspects and provide appropriate support or referrals when necessary.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Abd, E., Benson, H. A. E., Roberts, M. S., & Grice, J. E. (2018). Minoxidil skin delivery from nanoemulsion formulations containing eucalyptol or oleic acid: Enhanced diffusivity and follicular targeting. Pharmaceutics, 10(1), 19. https://doi.org/10.3390/pharmaceutics10010019

Abdalla, M. (2021). Non-surgical options to treat androgenic alopecia. World Family Medicine Journal/Middle East Journal of Family Medicine, 20(11). https://doi.org/10.5742/MEWFM.2021.94168

Abt, N. B., Quatela, O., Heiser, A., Jowett, N., Tessler, O., & Lee, L. N. (2018). Association of hair loss with health utility measurements before and after hair transplant surgery in men and women. JAMA Facial Plastic Surgery, 20(6), 495–500. https://doi.org/10.1001/jamafacial.2018.1052

Baek, J. Y., Kim, B. H., Kim, D.-W., Lee, W.-Y., Kim, C. E., Kim, H.-Y., Pyo, J., Park, E.-S., & Kang, K. S. (2023). Hair growth effect of dn106212 in c57bl/6 mouse and its network pharmacological mechanism of action. Current Issues in Molecular Biology, 45(6), 5071–5083. https://doi.org/10.3390/cimb45060322

Bao, L., Gong, L., Guo, M., Liu, T., Shi, A., Zong, H., Xu, X., Chen, H., Gao, X., & Li, Y. (2020). Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male androgenetic alopecia. Journal of Cosmetic and Laser Therapy: Official Publication of the European Society for Laser Dermatology, 22(1), 1–7. https://doi.org/10.1080/14764172.2017.1376094

Boersma, I., Oranje, A. P., Ramón Grimalt, Iorizzo, M., Bianca Maria Piraccini, & E.H.A.M. Verdonschot. (2014). The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. Indian Journal of Dermatology, Venereology and Leprology, 80(6), 521–521. https://doi.org/10.4103/0378-6323.144162

Cleveland Clinic. (2018). Hair loss in women | Cleveland Clinic. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/16921-hair-loss-in-women

Cleveland Clinic. (n.d.). Minoxidil topical solution or foam. Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/18238-minoxidil-topical-solution-or-foam

Cloyd, J. (2023, February 2). Top lab test to run on your iron deficiency anemia patients. Rupa Health. https://www.rupahealth.com/post/top-lab-test-to-run-on-your-iron-deficiency-anemia-patients

Cloyd, J. (2024, April 11). Guide to androgens: Definition, functions, and more. Rupa Health. https://www.rupahealth.com/post/androgen-hormones

Contin, L. A., Santos Júnior, J. B., Machado, C. J., & Rocha, V. B. (2023). Normal trichoscopic findings after hair transplantation in androgenetic alopecia: A prospective case series. Skin Appendage Disorders, 9(5), 361–365. https://doi.org/10.1159/000531220

Cumpata, A. J., Labusca, L., & Radulescu, L. M. (2024). Stem cell-based therapies for auditory hair cell regeneration in the treatment of hearing loss. Tissue Engineering. Part B, Reviews, 30(1), 15–28. https://doi.org/10.1089/ten.TEB.2023.0084

Department of Dermatology, Ministry of Interior, Riyadh, Saudi Arabia, Mansour Alkhalaf, H., Sahil Alotaibi, H., King Saud university, Riyadh, Saudi Arabia, Youssef M Alzaid, M., Department of Dermatology, Alnakheel medical complex, Riyadh, Saudi Arabia, Baqayis, A., King Saud Medical City, Riyadh, Saudi Arabia, Redn Almutairi, A., & King Saud University, Riyadh, Saudi Arabia. (2024). Review of stem cell therapy for hair loss. Journal of Dermatology Research Reviews & Reports, 1–5. https://doi.org/10.47363/JDMRS/2024(5)159

Desai, K., Almeida, B., & Miteva, M. (2021). Understanding hormonal therapies: Overview for the dermatologist focused on hair. Dermatology (Basel, Switzerland), 237(5), 786–791. https://doi.org/10.1159/000512888

Devjani, S., Ezemma, O., Ali, S., Collins, M., Kelley, K. J., & Senna, M. M. (2024). Scalp atrophy secondary to steroid use in patients with scarring alopecia: Are topical steroids superior to topical calcineurin inhibitors? International Journal of Dermatology, 63(1), 102–104. https://doi.org/10.1111/ijd.16918

Dhami, L. (2021). Psychology of hair loss patients and importance of counseling. Indian Journal of Plastic Surgery: Official Publication of the Association of Plastic Surgeons of India, 54(4), 411–415. https://doi.org/10.1055/s-0041-1741037

Dua, A., & Dua, K. (2010). Follicular unit extraction hair transplant. Journal of Cutaneous and Aesthetic Surgery, 3(2), 76–81. https://doi.org/10.4103/0974-2077.69015

Egger, A., Tomic-Canic, M., & Tosti, A. (2020). Advances in stem cell-based therapy for hair loss. CellR4—Repair, Replacement, Regeneration, & Reprogramming, 8, e2894.

Elsayed, A. A. A., Abdelaal, K. M., Abdelghaffar, A. M. M., Mohamed, E. E. H., Mahran, T. M. A., Ahmed, M. S. M., Ibrahim, A. M., & Mansour, A. A. (2019). Poor outcome of surgical management of acute malfunctioning mechanical mitral valve during pregnancy. Should centers with limited resources find different options? The Heart Surgery Forum, 22(5), E405–E410. https://doi.org/10.1532/hsf.2497

Endo, Y., Obayashi, Y., Murakoshi, M., Saito, J., & Ueki, R. (2023). Clinical and phototrichogrammatic evaluation of estradiol replacement therapy on hair growth in postmenopausal Japanese women with female pattern hair loss: A pilot study. International Journal of Women’s Dermatology, 9(4), e109. https://doi.org/10.1097/JW9.0000000000000109

Fabbrocini, G., Cantelli, M., Masarà, A., Annunziata, M. C., Marasca, C., & Cacciapuoti, S. (2018). Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. International Journal of Women’s Dermatology, 4(4), 203–211. https://doi.org/10.1016/j.ijwd.2018.05.001

Fiedler, V. C. (1993). Alopecia areata, topical minoxidil, and balanced reviews-reply. Archives of Dermatology, 129(7), 909. https://doi.org/10.1001/archderm.1993.01680280099025

Gadzhigoroeva, A., Guzman-Sanchez, D., Firooz, A., Moravvej, H., Espinoza, N., Romanova, Y., Suárez, H. V. M., Simoes, M. M., & Potekaev, N. N. (2020, December 17). Covid-19 can exacerbate pattern hair loss and trigger telogen effluvium – the role of proteoglycan replacement therapy with nourkrin® in clinical treatment of covid-19 associated hair loss. https://doi.org/10.31219/osf.io/m7b3j

Gangadaran, P., Rajendran, R. L., Kwack, M. H., Jeyaraman, M., Hong, C. M., Sung, Y. K., & Ahn, B.-C. (2022). Application of cell-derived extracellular vesicles and engineered nanovesicles for hair growth: From mechanisms to therapeutics. Frontiers in Cell and Developmental Biology, 10, 963278. https://doi.org/10.3389/fcell.2022.963278

Garg, A., & Garg, S. (2018). Donor harvesting: Follicular unit excision. Journal of Cutaneous and Aesthetic Surgery, 11(4), 195. https://doi.org/10.4103/jcas.jcas_123_18

Gelhorn, H. L., Cutts, K., Edson-Heredia, E., Wright, P., Delozier, A., Shapiro, J., Senna, M., & Tosti, A. (2022). The relationship between patient-reported severity of hair loss and health-related quality of life and treatment patterns among patients with alopecia areata. Dermatology and Therapy, 12(4), 989–997. https://doi.org/10.1007/s13555-022-00702-4

Gentile, P., Cole, J. P., Cole, M. A., Garcovich, S., Bielli, A., Scioli, M. G., Orlandi, A., Insalaco, C., & Cervelli, V. (2017). Evaluation of not-activated and activated prp in hair loss treatment: Role of growth factor and cytokine concentrations obtained by different collection systems. International Journal of Molecular Sciences, 18(2), 408. https://doi.org/10.3390/ijms18020408

Gentile, P., & Garcovich, S. (2019). Advances in regenerative stem cell therapy in androgenic alopecia and hair loss: Wnt pathway, growth-factor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development. Cells, 8(5), 466. https://doi.org/10.3390/cells8050466

Gentile, P., & Garcovich, S. (2020). Autologous activated platelet-rich plasma (Aa-prp) and non-activated (A-prp) in hair growth: A retrospective, blinded, randomized evaluation in androgenetic alopecia. Expert Opinion on Biological Therapy, 20(3), 327–337. https://doi.org/10.1080/14712598.2020.1724951

Gilhar, A., Keren, A., Ullmann, Y., Wu, J., & Paus, R. (2022). Effect of minoxidil formulations on human scalp skin xenotransplants on SCID mice: A novel pre-clinical in vivo assay for androgenetic alopecia research. Experimental Dermatology, 31(6), 980–982. https://doi.org/10.1111/exd.14523

Gómez, L. F. U., Gaitán-Lee, H., Duarte, M. A., Halley, P. D., Jaramillo, A. R., & García, E. L. (2021). Precision and accuracy of pre-surgical planning of non-cemented total hip replacement with calibrated digital images and acetates. Journal of Orthopaedic Surgery and Research, 16, 431. https://doi.org/10.1186/s13018-021-02584-2

Gomolin, A., Litvinov, I. V., & Netchiporouk, E. (2020). Oral minoxidil: A possible new therapy for androgenetic alopecia. Journal of Cutaneous Medicine and Surgery, 24(1), 88–89. https://doi.org/10.1177/1203475419879887

Gupta, A. K., Bamimore, M. A., & Foley, K. A. (2022). Efficacy of non-surgical treatments for androgenetic alopecia in men and women: A systematic review with network meta-analyses, and an assessment of evidence quality. The Journal of Dermatological Treatment, 33(1), 62–72. https://doi.org/10.1080/09546634.2020.1749547

Gupta, A. K., & Foley, K. A. (2014). 5% Minoxidil: Treatment for female pattern hair loss. Skin Therapy Letter, 19(6), 5–7.

Harvard Health Publishing. (2018, November 14). Treating female pattern hair loss - Harvard Health. Harvard Health. https://www.health.harvard.edu/staying-healthy/treating-female-pattern-hair-loss

Hermasch, M. A., Schön, M. P., Betz, R. C., & Frank, J. (2019). Two females with hair loss. Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG, 17(8), 845–847. https://doi.org/10.1111/ddg.13886

Ho, C.-Y., Chen, J. Y.-F., Hsu, W.-L., Yu, S., Chen, W.-C., Chiu, S.-H., Yang, H.-R., Lin, S.-Y., & Wu, C.-Y. (2023). Female pattern hair loss: An overview with focus on the genetics. Genes, 14(7), 1326. https://doi.org/10.3390/genes14071326

Hughes, E. C., Syed, H. A., & Saleh, D. (2024). Telogen effluvium. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430848/#:~:text=Telogen%20effluvium%20is%20the%20excessive

Hwang, H. W., Ryou, S., Jeong, J. H., Lee, J. W., Lee, K.-J., Lee, S. B., Shin, H.-T., Byun, J. W., Shin, J., & Choi, G. S. (2024). The quality of life and psychosocial impact on female pattern hair loss. Annals of Dermatology, 36(1), 44–52. https://doi.org/10.5021/ad.23.082

Ilovayskaya, I., & Zektser, V. (2024). Hypogonadism as a consequence of craniopharyngioma in female patients: Comparison of childhood and adult onset and effects of estrogen replacement therapy. Endocrine, 85(3), 1425–1434. https://doi.org/10.1007/s12020-024-03872-7

Ik Jun Moon, Hae Kyeong Yoon, Kim, D., Myung Eun Choi, Seung Hee Han, June Hyun Park, Sun Woo Hong, Cho, H., Lee, D.-K., & Chong Hyun Won. (2022). Efficacy of asymmetric siRNA targeting androgen receptors for the treatment of androgenetic alopecia. Molecular Pharmaceutics, 20(1), 128–135. https://doi.org/10.1021/acs.molpharmaceut.2c00510

John Hopkins Medicine. (n.d.). Platelet-rich plasma (PRP) treatment. Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/plateletrich-plasma-prp-treatment

Kaku, Y., Tanizaki, H., Tanioka, M., Sakabe, J., Miyagawa-Hayashino, A., Tokura, Y., Miyachi, Y., & Kabashima, K. (2012). Sebaceous carcinoma arising at a chronic candidiasis skin lesion of a patient with keratitis-ichthyosis-deafness (Kid) syndrome. The British Journal of Dermatology, 166(1), 222–224. https://doi.org/10.1111/j.1365-2133.2011.10521.x

Kanzaki, S., Toyoda, M., Umezawa, A., & Ogawa, K. (2020). Application of mesenchymal stem cell therapy and inner ear regeneration for hearing loss: A review. International Journal of Molecular Sciences, 21(16), 5764. https://doi.org/10.3390/ijms21165764

Keaney, T. (2015). Emerging therapies for androgenetic alopecia. Journal of Drugs in Dermatology: JDD, 14(9), 1036–1040.

Kinoshita-Ise, M., Fukuyama, M., & Ohyama, M. (2023). Recent advances in understanding of the etiopathogenesis, diagnosis, and management of hair loss diseases. Journal of Clinical Medicine, 12(9), 3259. https://doi.org/10.3390/jcm12093259

Krishnamurthy, R., Jaganathan, B. K., Rangaswamy, R., & Jeganathan, C. (2024). A novel method of intraoperative calculation in follicular unit transplantation: “The sequential strip and FUE method.” Aesthetic Plastic Surgery, 48(3), 297–303. https://doi.org/10.1007/s00266-023-03300-7

KULLAB, J., Schielein, M. C., Stuhlmann, C. F. Z., Tizek, L., Wecker, H., Kain, A., Biedermann, T., & Zink, A. (2023). Out-of-pocket costs in alopecia areata: A cross-sectional study in German-speaking countries. Acta Dermato-Venereologica, 103, 4441. https://doi.org/10.2340/actadv.v103.4441

Lalu, M., Manickam, N., Gopalan, K., & Vellaisamy, S. G. (2021). Impact on quality of life among females with diffuse hair loss at a tertiary care centre: A cross-sectional study. Journal of Clinical and Diagnostic Research. https://doi.org/10.7860/JCDR/2021/50148.15565

Larrondo, J., Petela, J., & McMichael, A. J. (2022). Transitory hair growth using platelet‐rich plasma therapy in stabilized central centrifugal cicatricial alopecia. Dermatologic Therapy, 35(11), e15798. https://doi.org/10.1111/dth.15798

Lee, C.-Y., Su, C.-H., Chiang, C.-Y., Wu, C.-N., & Kuan, Y.-H. (2021). Observation of the expression of vascular endothelial growth factor and the potential effect of promoting hair growth treated with Chinese herbal BeauTop. Evidence-Based Complementary and Alternative Medicine, 2021, 1–8. https://doi.org/10.1155/2021/6667011

Lee, Y. I., Ham, S., Lee, S. G., Jung, I., Suk, J., Yoo, J., Choi, S.-Y., & Lee, J. H. (2022). An exploratory in vivo study on the effect of annurca apple extract on hair growth in mice. Current Issues in Molecular Biology, 44(12), 6280–6289. https://doi.org/10.3390/cimb44120428

Lilikakis, A., Gakis, E., Zacharopoulos, K., Papapolychroniou, T., Kotsiopoulos, K., & Michelinakis, E. (2004, February 1). Skin disorders around surgical wounds for total joint replacement. Semantic Scholar. https://www.semanticscholar.org/paper/SKIN-DISORDERS-AROUND-SURGICAL-WOUNDS-FOR-TOTAL-Lilikakis-Gakis/4aa289d3c375680434fbf833d8d441c14f4e063b

Lin, W., Xiang, L.-J., Shi, H.-X., Zhang, J., Jiang, L., Cai, P., Lin, Z.-L., Lin, B.-B., Huang, Y., Zhang, H.-L., Fu, X.-B., Guo, D.-J., Li, X.-K., Wang, X.-J., & Xiao, J. (2015). Fibroblast growth factors stimulate hair growth through β-catenin and Shh expression in C57BL/6 mice. BioMed Research International, 2015, 1–9. https://doi.org/10.1155/2015/730139

Maholy, N. (2023, April 14). How to reduce stress through mind-body therapies. Rupa Health. https://www.rupahealth.com/post/how-to-reduce-stress-through-mind-body-therapies

Maletic, A., Dumic-Cule, I., Zic, R., & Milosevic, M. (2024). Impact of hair transplantation on quality of life. Aesthetic Plastic Surgery, 48(9), 1825–1830. https://doi.org/10.1007/s00266-023-03781-6

Marchitto, M. C., Qureshi, A., Marks, D., Awosika, O., Rengifo-Pardo, M., & Ehrlich, A. (2019). Emerging nonsteroid-based procedural therapies for alopecia areata: A systematic review. Dermatologic Surgery, 45(12), 1484–1506. https://doi.org/10.1097/DSS.0000000000002053

Marija, I. B. (2014). Human hair follicle: An update on biology and perspectives in hair growth disorders treatment. Hair: Therapy & Transplantation, 04. https://doi.org/10.4172/2167-0951.1000115

Mayo Clinic. (2022, March 22). Chemotherapy. Mayo Clinic. https://www.mayoclinic.org/tests-procedures/chemotherapy/about/pac-20385033#:~:text=Overview

Mayo Clinic. (n.d.). Finasteride (oral route) description and brand names. Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/finasteride-oral-route/description/drg-20063819

McMichael, A., Pham, H., von Grote, E., & Meckfessel, M. H. (2016). Efficacy and safety of minoxidil 2% solution in combination with a botanical hair solution in women with female pattern hair loss/androgenic alopecia. Journal of Drugs in Dermatology: JDD, 15(4), 398–404.

Melo, D. F., Cortez de Almeida, R. F., Frattini, S. C., Santos, L. D. N., & Ramos, P. M. (2022). Minimally invasive procedures for the management of female pattern hair loss. Journal of Cosmetic Dermatology, 21(11), 5405–5408. https://doi.org/10.1111/jocd.15160

Mesinkovska, N., Craiglow, B., Ball, S. G., Morrow, P., Smith, S. G., Pierce, E., & Shapiro, J. (2023). The invisible impact of a visible disease: Psychosocial impact of alopecia areata. Dermatology and Therapy, 13(7), 1503–1515. https://doi.org/10.1007/s13555-023-00941-z

Mounsey, A. L., & Reed, S. W. (2009). Diagnosing and treating hair loss. American Family Physician, 80(4), 356–362.

Msiii, N. K. B., Msiii, C. K. M., & Rashid, R. M. (2014). Surgical hair restoration options. Semantic Scholar. https://www.semanticscholar.org/paper/Surgical-Hair-Restoration-Options-Msiii-Msiii/216260b06a99b7cbf810c2deb3a4cc433312ff33

Mustieles, V., Lascouts, A., Pozo, O. J., Haro, N., Lyon-Caen, S., Jedynak, P., Bayat, S., Thomsen, C., Sakhi, A. K., Sabaredzovic, A., Slama, R., Ouellet-Morin, I., & Philippat, C. (2023). Longitudinal associations between prenatal exposure to phthalates and steroid hormones in maternal hair samples from the sepages cohort. Environmental Science & Technology, 57(48), 19202–19213. https://doi.org/10.1021/acs.est.3c03401

Nestor, M. S., Ablon, G., Gade, A., Han, H., & Fischer, D. L. (2021). Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. Journal of Cosmetic Dermatology, 20(12), 3759–3781. https://doi.org/10.1111/jocd.14537

Pillai, J., & Mysore, V. (2021). Role of low-level light therapy (LLLT) in androgenetic alopecia. Journal of Cutaneous and Aesthetic Surgery, 14(4), 385. https://doi.org/10.4103/jcas.jcas_218_20

Talebzadeh, A. T., & Talebzadeh, N. (n.d.). Stem cell applications in human hair growth: A literature review. Cureus, 15(4), e37439. https://doi.org/10.7759/cureus.37439

Thom, E. (2006). Nourkrin®: Objective and subjective effects and tolerability in persons with hair loss. Journal of International Medical Research, 34(5), 514–519. https://doi.org/10.1177/147323000603400508

Wadstein, J., Thom, E., & Gadzhigoroeva, A. (2020). Integral roles of specific proteoglycans in hair growth and hair loss: Mechanisms behind the bioactivity of proteoglycan replacement therapy with Nourkrin® with Marilex® in pattern hair loss and telogen effluvium. Dermatology Research and Practice, 2020, 1–17. https://doi.org/10.1155/2020/8125081

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Women's Health
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! 👋 Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.